NCT07278518 Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
| NCT ID | NCT07278518 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Medical University of South Carolina |
| Condition | Opioid Use Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2026-05-19 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2026-05-19 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to develop and pilot test a patient decision aid (PtDA) for emergency department (ED)-initiated buprenorphine treatment for opioid use disorder (OUD). The PtDA will be evaluated for acceptability, impact on patient knowledge, decisional conflict, and buprenorphine uptake compared to treatment as usual (TAU).
Eligibility Criteria
Inclusion Criteria: * Age ≥18 * DSM-5 criteria for moderate-to-severe OUD * Speaks and reads English * Not currently prescribed MOUD * Post-ED discharge patients with access to video/email Exclusion Criteria: \- Prisoners
Contact & Investigator
Lindsey Jennings, MD, MPH
PRINCIPAL INVESTIGATOR
Medical University of South Carolina
Frequently Asked Questions
Who can join the NCT07278518 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07278518 currently recruiting?
Yes, NCT07278518 is actively recruiting participants. Contact the research team at jennil@musc.edu for enrollment information.
Where is the NCT07278518 trial being conducted?
This trial is being conducted at Charleston, United States.
Who is sponsoring the NCT07278518 clinical trial?
NCT07278518 is sponsored by Medical University of South Carolina. The principal investigator is Lindsey Jennings, MD, MPH at Medical University of South Carolina. The trial plans to enroll 20 participants.